FI52586C - Menetelmä terapeuttisesti käytettävien kefalosporiiniyhdisteiden valmi stamiseksi - Google Patents

Menetelmä terapeuttisesti käytettävien kefalosporiiniyhdisteiden valmi stamiseksi

Info

Publication number
FI52586C
FI52586C FI712153A FI215371A FI52586C FI 52586 C FI52586 C FI 52586C FI 712153 A FI712153 A FI 712153A FI 215371 A FI215371 A FI 215371A FI 52586 C FI52586 C FI 52586C
Authority
FI
Finland
Prior art keywords
ivat
preparation
therapeutically active
active cephalosporins
cephalosporins
Prior art date
Application number
FI712153A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI52586B (ro
Inventor
Michihiko Ochiai
Osami Aki
Akira Morimoto
Taiiti Okada
Katsutada Masuda
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of FI52586B publication Critical patent/FI52586B/fi
Application granted granted Critical
Publication of FI52586C publication Critical patent/FI52586C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI712153A 1970-11-10 1971-07-29 Menetelmä terapeuttisesti käytettävien kefalosporiiniyhdisteiden valmi stamiseksi FI52586C (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP45099203A JPS4948559B1 (ro) 1970-11-10 1970-11-10

Publications (2)

Publication Number Publication Date
FI52586B FI52586B (ro) 1977-06-30
FI52586C true FI52586C (fi) 1977-10-10

Family

ID=14241076

Family Applications (1)

Application Number Title Priority Date Filing Date
FI712153A FI52586C (fi) 1970-11-10 1971-07-29 Menetelmä terapeuttisesti käytettävien kefalosporiiniyhdisteiden valmi stamiseksi

Country Status (20)

Country Link
US (1) US3878204A (ro)
JP (1) JPS4948559B1 (ro)
AR (1) AR196864A1 (ro)
AT (1) AT310354B (ro)
AU (1) AU456913B2 (ro)
BE (1) BE770804A (ro)
CA (1) CA992071A (ro)
CH (1) CH592678A5 (ro)
CS (1) CS171236B2 (ro)
ES (1) ES393706A1 (ro)
FI (1) FI52586C (ro)
FR (1) FR2113830B1 (ro)
GB (1) GB1304647A (ro)
NL (1) NL7110599A (ro)
NO (1) NO138375C (ro)
PL (1) PL87678B1 (ro)
RO (2) RO60523A (ro)
SE (1) SE386681B (ro)
SU (2) SU425401A3 (ro)
ZA (1) ZA715018B (ro)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1030523A (en) * 1973-06-25 1978-05-02 Taiiti Okada Cephalosporins
DK635474A (ro) * 1974-02-05 1975-10-13 Ciba Geigy Ag
JPS5133260U (ro) * 1974-09-04 1976-03-11
BE833640A (fr) * 1974-09-20 1976-03-19 Nouvelles cephalosporines et leur preparation
US4088815A (en) * 1974-09-20 1978-05-09 E. R. Squibb & Sons, Inc. 3-Heterothio-7-ureido cephalosporins
CN1531539A (zh) 2001-04-19 2004-09-22 ��ŷ�����¶����ǹɷ����޹�˾ 用α-酮酸衍生物制备头孢烷酸衍生物的酶促方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1279402A (en) * 1968-06-14 1972-06-28 Glaxo Lab Ltd Improvements in or relating to cephalosporin derivatives
GB1277415A (en) * 1968-06-14 1972-06-14 Glaxo Lab Ltd Improvements in or relating to cephalosporin derivatives
US3641021A (en) * 1969-04-18 1972-02-08 Lilly Co Eli 3 7-(ring-substituted) cephalosporin compounds
US3578661A (en) * 1969-06-02 1971-05-11 Bristol Myers Co Process for the preparation of 7-(alpha-(4 - pyridylthio)acetamido)cephalosporanic acids

Also Published As

Publication number Publication date
RO62792A (fr) 1977-11-15
RO60523A (ro) 1977-05-15
ZA715018B (en) 1972-04-26
FR2113830A1 (ro) 1972-06-30
FI52586B (ro) 1977-06-30
SU425401A3 (ru) 1974-04-25
DE2137386A1 (de) 1972-05-31
DE2137386B2 (de) 1976-04-29
SE386681B (sv) 1976-08-16
GB1304647A (ro) 1973-01-24
NO138375B (no) 1978-05-16
FR2113830B1 (ro) 1974-11-15
AT310354B (de) 1973-09-25
CH592678A5 (ro) 1977-10-31
AR196864A1 (es) 1974-02-28
NO138375C (no) 1978-08-23
CA992071A (en) 1976-06-29
NL7110599A (ro) 1972-05-15
US3878204A (en) 1975-04-15
AU3177871A (en) 1973-02-01
AU456913B2 (en) 1975-01-16
ES393706A1 (es) 1974-07-16
PL87678B1 (ro) 1976-07-31
CS171236B2 (ro) 1976-10-29
JPS4948559B1 (ro) 1974-12-21
SU591151A3 (ru) 1978-01-30
BE770804A (fr) 1972-01-31

Similar Documents

Publication Publication Date Title
FI49035C (fi) Menetelmä terapeuttisesti käytettävän 2-bromi-alfa-ergokryptiinin valm istamiseksi.
FI48590C (fi) Menetelmä terapeuttisesti käytettävien atsaspiroalkaanidioniyhdisteide n valmistamiseksi.
FI48062C (fi) Menetelmä ksylitolin valmistamiseksi
NO137694C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner
NO142033C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive isopropylamino-3-fenoksypropanoler
SE7700442L (sv) Forfarande for framstellning av 6-aminopenicillansyra
NO138999C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive difenylyl-alkanoylaminopyridiner
NO137858C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indanoner
FI49512C (fi) Menetelmä uusien terapeuttisesti aktiivisten s-triatsinyylipiperatsiin ijohdannaisten valmistamiseksi.
FI47365C (fi) Menetelmä valmistaa uusia terapeuttisesti vaikuttavia indolijohdannais ia.
FI49827C (fi) Menetelmä terapeuttisesti vaikuttavien substituoitujen 3-hydroksimetyy li-isokinoliinien valmistamiseksi.
FI52586C (fi) Menetelmä terapeuttisesti käytettävien kefalosporiiniyhdisteiden valmi stamiseksi
FI52726C (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten ergoleenijohdannaist en valmistamiseksi.
FI51484C (fi) Menetelmä 7beta-(D-5-amino-5-karboksivaleramido)-3-(karbamoyylioksimet yyli)-7-metoksi-3-kefem-4-karboksyylihappo-antibiootin valmistamiseksi .
FI49032C (fi) Menetelmä terapeuttisesti aktiivisten 7-nitro-8-hydroksi-kinoliini-est erien valmistamiseksi.
FI54290C (fi) Foerfarande foer framstaellning av farmakologiskt aktiva aminospirodibenzocykloheptenfoereningar
NO137727C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-fenyl-3-hydroksy-3-metyltriazener
NO137695C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-tienylmetyl-heterocykliske forbindelser
FI50875C (fi) Menetelmä terapeuttisesti aktiivisten dihydro-2-aminoisokinoliinien va lmistamiseksi.
FI47189C (fi) Tapa valmistaa terapeuttisesti vaikuttavia d-lysergiinihappo-N-fenyyli piperatsideja.
NO137893C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-m-trifluormetylfenyl-2-cyanoalkylaminopropaner
FI52577C (fi) Menetelmä terapeuttisesti käytettävien fenatsiinijohdannaisten valmist amiseksi.
NO136977C (no) Analogifremgangsm}te for mstilling av terapeutisk aktive oksazolidiner
FI45045C (fi) Menetelmä uusien terapeuttisesti vaikuttavien 5-nitro-2-furyyli-isoksa tsolijohdannaisten valmistamiseksi.
FI50243C (fi) Menetelmä terapeuttisesti vaikuttavien N-substituoitujen 3-hydroksi-9- atsamorfinaanien valmistamiseksi.